TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/16/23 16:15 | 11/14/23 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Bozic Carmen | MA | O | EVP,CMO | S | -2,152 | 380.82 | 0 | -6 | -16 | 29 | D | ||||||||||||||
11/2/23 16:07 | 10/31/23 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Bozic Carmen | MA | O | EVP,CMO | S | -2,011 | 355.92 | 0 | -6 | -14 | 35 | D | ||||||||||||||
10/19/23 16:18 | 10/17/23 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Bozic Carmen | MA | O | EVP,CMO | S | -2,109 | 373.25 | 0 | -6 | -12 | 41 | D | ||||||||||||||
10/5/23 16:30 | 10/3/23 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Bozic Carmen | MA | O | EVP,CMO | S | -1,951 | 345.28 | 0 | -6 | -11 | 46 | D | ||||||||||||||
9/21/23 16:15 | 9/19/23 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Bozic Carmen | MA | O | EVP,CMO | S | -1,984 | 351.00 | 0 | -6 | -10 | 52 | D | ||||||||||||||
9/7/23 16:29 | 9/5/23 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Bozic Carmen | MA | O | EVP,CMO | S | -1,993 | 352.66 | 0 | -6 | -9 | 58 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |